These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 9831892

  • 1. Metabolism of the vitamin D3 analogue EB1089 alters receptor complex formation and reduces promoter selectivity.
    Quack M, Mørk Hansen C, Binderup E, Kissmeyer AM, Carlberg C.
    Br J Pharmacol; 1998 Oct; 125(4):607-14. PubMed ID: 9831892
    [Abstract] [Full Text] [Related]

  • 2. Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity.
    Quack M, Clarin A, Binderup E, Björkling F, Hansen CM, Carlberg C.
    J Cell Biochem; 1998 Dec 01; 71(3):340-50. PubMed ID: 9831071
    [Abstract] [Full Text] [Related]

  • 3. The anti-proliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity.
    Nayeri S, Danielsson C, Kahlen JP, Schräder M, Mathiasen IS, Binderup L, Carlberg C.
    Oncogene; 1995 Nov 02; 11(9):1853-8. PubMed ID: 7478614
    [Abstract] [Full Text] [Related]

  • 4. Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs.
    Quack M, Carlberg C.
    Mol Pharmacol; 1999 Jun 02; 55(6):1077-87. PubMed ID: 10347251
    [Abstract] [Full Text] [Related]

  • 5. Differential apoptotic response of human melanoma cells to 1 alpha,25-dihydroxyvitamin D3 and its analogues.
    Danielsson C, Fehsel K, Polly P, Carlberg C.
    Cell Death Differ; 1998 Nov 02; 5(11):946-52. PubMed ID: 9846181
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity.
    Danielsson C, Mathiasen IS, James SY, Nayeri S, Bretting C, Hansen CM, Colston KW, Carlberg C.
    J Cell Biochem; 1997 Sep 15; 66(4):552-62. PubMed ID: 9282333
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The impact of functional vitamin D(3) receptor conformations on DNA-dependent vitamin D(3) signaling.
    Quack M, Carlberg C.
    Mol Pharmacol; 2000 Feb 15; 57(2):375-84. PubMed ID: 10648648
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The 1,25-dihydroxyvitamin D3 (VD) analogues MC903, EB1089 and KH1060 activate the VD receptor: homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors.
    Carlberg C, Mathiasen IS, Saurat JH, Binderup L.
    J Steroid Biochem Mol Biol; 1994 Nov 15; 51(3-4):137-42. PubMed ID: 7981122
    [Abstract] [Full Text] [Related]

  • 14. EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro.
    James SY, Mercer E, Brady M, Binderup L, Colston KW.
    Br J Pharmacol; 1998 Nov 15; 125(5):953-62. PubMed ID: 9846632
    [Abstract] [Full Text] [Related]

  • 15. Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.
    González-Avión XC, Mouriño A, Rochel N, Moras D.
    J Med Chem; 2006 Mar 09; 49(5):1509-16. PubMed ID: 16509569
    [Abstract] [Full Text] [Related]

  • 16. Sequential versus combined treatment of human breast cancer cells with antiestrogens and the vitamin D analogue EB1089 and evaluation of predictive markers for vitamin D treatment.
    Christensen GL, Jepsen JS, Fog CK, Christensen IJ, Lykkesfeldt AE.
    Breast Cancer Res Treat; 2004 May 09; 85(1):53-63. PubMed ID: 15039597
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL, Schwartz GG, Selzer MG, Burnstein KL, Zhuang SH, Block NL, Binderup L.
    Cancer Epidemiol Biomarkers Prev; 1999 Mar 09; 8(3):241-8. PubMed ID: 10090302
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.